This engaging panel discussion will bring together representatives from the 2026 FOYA Category Winning projects alongside a panel of seasoned FOYA judges.

Featuring insights from this year’s winning organizations, including Sanofi S.A., Takeda, Bayer AG, Hepalink Parmaceutical Group Co., Ltd., Eli Lilly & Company, AstraZeneca, BSP Pharmaceuticals SpA, Chugai Pharma Manufacturing Co., and FUJIFILM Biotechnologies, this session will provide an inside look at the real-world decisions, partnerships, and innovations behind some of the industry’s most exemplary facilities and projects.

Explore the ideas, strategies, and innovations behind this year’s award-winning projects, highlighting how leading organizations are responding to evolving demands across facility design, construction, operations, sustainability, digital transformation, and patient impact.
Hear from winning teams share the vision behind their projects, key challenges encountered, lessons learned, and the solutions that ultimately distinguished their submissions.
Look across the 2026 winning projects for broader industry trends, examining how collaboration, technology, operational excellence, sustainability, and forward-thinking facility strategies are shaping the next generation of pharmaceutical manufacturing.

Attendees will leave with practical insights and fresh perspectives they can apply within their own organizations as the life sciences industry continues to raise the bar for facility excellence.

Carmel R. Keane

Vice President Global Engineering, Pfizer

Appearances